Drug Research

Takeda and Theravance Biopharma, Inc. announced that the companies have entered into a global license, development and commercialization agreement for TD-8954, a selective 5-HT4 receptor agonist being investigated for potential use in the treatment of gastrointestinal motility disorders, including...

GSK presented new data for its meningococcal group B vaccine, Bexsero®,1   comparing safety and immunogenicity with different dosing schedules in infants and young children, at the annual meeting of the European Society for Paediatric Infectious Diseases (ESPID). ...

Amgen announced that The Lancet published results from a Phase 3 randomized, double-blind, placebo-controlled study of Nplate in children with symptomatic immune thrombocytopenia.   The study showed that 52 percent of Nplate patients achieved a durable...

  FIrst PCSK9 Inhibitor in Japan,Providing A new TREATMENT option for certain patients who have high risk in cardiovascular events and do not adequately respond to statins. World pharma today/Drug research/- Amgen Astellas BioPharma K.K. (Headquarters,...

New studies will evaluate the effect of JARDIANCE for the treatment of chronic heart failure There are approximately 26 million people worldwide, and 5.7 million people in the U.S., suffering from chronic heart failure The studies build...

Only Manufacturer to Offer the Antibiotic in a Ready-to-Use Premixed Presentation World pharma today/Press releases /-Advancing Baxter’s longstanding commitment to provide hospitals with convenient presentations of medications that drive efficiency during drug preparation and enhance patient...

Every month millions of Americans pick up their prescription at the pharmacy, only to discover that their pill looks different than the month before. Last month’s oval, white pills embossed with “3972V” are now round, and display imprint “ML24”....